Rami Slijmoplossende indications
Rami Slijmoplossende is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.
Uses of Rami Slijmoplossende in details
Rami Slijmoplossende is used along with other medications as adjunctive therapy to treat conditions of the respiratory tract which causes difficulty in breathing, including chronic obstructive airways disease.
Rami Slijmoplossende description
Rami Slijmoplossende is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Rami Slijmoplossende should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Rami Slijmoplossende is produced by alkylation of cysteine with chloroacetic acid.
Rami Slijmoplossende dosage
Capsule: Adult and Children ≥12 years: 1 capsule. Forte Suspension: Adult and Children ≥12 years: 5 mL (1 tsp). 100 mg/5 mL Pediatric Suspension: Children 8-12 years: 15 mL (3 tsp), 4-7 years: 10 mL (2 tsp), 2-3 years: 5 mL (1 tsp). 200 mg/5 mL Pediatric Suspension: Children 8-12 years: 7.5 mL, 4-7 years: 5 mL, 2-3 years: 2.5 mL. InfantOral Drops:
Infants 1-2 years: 1.5 mL. All doses to be taken orally every 8 hrs.
Rami Slijmoplossende interactions
mixing Rami Slijmoplossende with pholcodine linctus causes precipitation of Rami Slijmoplossende from solution but no information is given on whether this incompatibility is with the pholcodine or some component of the formulation used.
Rami Slijmoplossende side effects
Capsules, Syrup and Paediatric Syrup:
Immune System Disorders
There have been reports of anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions.
Capsules and Syrup:
Gastrointestinal disorders
There have been rare reports of gastrointestinal bleeding occurring during treatment with Rami Slijmoplossende.
Rami Slijmoplossende contraindications
Adult Syrup: Gastroduodenal ulceration.
Children Syrup: Known hypersensitivity to any of the components of Rami Slijmoplossende Children Syrup, in particular to parabens. Children <2 years due to risk of worsening airway congestion.
Active ingredient matches for Rami Slijmoplossende:
Carbocisteine in Netherlands.
List of Rami Slijmoplossende substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Purasol (Hong Kong) | |
| Recofluid (Italy) | |
| Reodyn (Finland) | |
| Reomucil (Italy) | |
| Rhinamex (Thailand) | |
| Rhinamex 250 mg/5 mL x 60 mL x 12's | |
| Rhinathiol (Belgium, Benin, Bulgaria, Burkina Faso, Cameroon, Central African Republic, Chad, Congo, Cote D'ivoire, France, Gabon, Ghana, Guinea, Hong Kong, Hungary, Kenya, Madagascar, Malaysia, Mali, Malta, Mauritania, Mauritius, Niger, Nigeria, Oman, Portugal, Romania, Senegal, Singapore, Switzerland, Taiwan, Tanzania, Thailand, Togo, Tunisia, Uganda, Vietnam, Zaire) | |
| Gel; Oral; Carbocisteine 75 mg / ml (sanofi-aventis) | |
| Syrup; Oral; Carbocisteine 2% (sanofi-aventis) | |
| Rhinathiol 375 mg x 30's (sanofi-aventis) | |
| Rhinathiol 250 mg/5 mL x 125 mL (sanofi-aventis) | $ 26.80 |
| Rhinathiol 100 mg/5 mL x 125 mL (sanofi-aventis) | $ 18.90 |
| Rhinathiol 375 mg x 3 Blister x 10 Tablet (sanofi-aventis) | |
|
sponsored
| |
| Rhinathiol 2 % x 125 mL (sanofi-aventis) | |
| Rhinathiol 5 % x 125 mL (sanofi-aventis) | |
| Rhinathiol 250 mg/5 mL x 125 mL x 1's (sanofi-aventis) | |
| Rhinathiol 100 mg/5 mL x 125 mL x 1's (sanofi-aventis) | |
| Rhinathiol 375 mg (sanofi-aventis) | |
| Rhinathiol 50 mg/1 mL x 125 mL (sanofi-aventis) | |
| Rhinathiol Adult syr 250 mg/5 mL 125 mL x 1's (sanofi-aventis) | |
| Rhinathiol Childn syr 100 mg/5 mL 125 mL x 1's (sanofi-aventis) | |
| Rhinathiol 2% Children (Malta) | |
| Rhinathiol 2% Children and Infants (Lithuania) | |
| Rhinathiol 2% Expectorant Carbocistéine Enfant (France) | |
| Rhinathiol 20 mg/ml (Hungary) | |
| Rhinathiol 5% (Malta) | |
| Rhinathiol 5% Expectorant Carbocistéine (France) | |
| Rhinathiol 5% Expectorant Carbocistéine Enfant (France) | |
| Rhinathiol 50 mg/ml (Hungary) | |
| Rhinathiol 5g/100ml (Oman) | |
| Rhinathiol a la Carbocisteine Adultes sans sucre | |
| Syrup; Oral; Carbocisteine 5% | |
| Rhinathiol Carbocistéine (France) | |
| Rhinathiol carbocisteïne (Netherlands) | |
| Rhinathiol Children (Bulgaria) | |
| Rhinathiol Children and Infants (Lithuania) | |
| Rhinathiol Expectorant | |
| Syrup; Oral; Carbocisteine 15% | |
| Rhinathiol Expectorant sans sucre | |
| Syrup; Oral; Carbocisteine 15% | |
| Rhinathiol Infants (Oman) | |
| Rhinathiol Infants 2% (Oman) | |
| Rhinathiol Kids (Thailand) | |
| Rhinathiol Kids 100 mg/5 mL x 60 mL (sanofi-aventis) | |
| Rhinathiol Kids 100 mg/5 mL x 1 L (sanofi-aventis) | |
| Rhinathiol Kids ped syr 100 mg/5 mL 1 L x 1's (sanofi-aventis) | |
| Rhinathiol Kids ped syr 100 mg/5 mL 60 mL x 1's (sanofi-aventis) | |
| Rhinathiol Kinder (Switzerland) | |
See 960 substitutes for Rami Slijmoplossende | |
References
- PubChem. "carbocysteine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "carbocysteine". http://www.drugbank.ca/drugs/DB04339 (accessed September 17, 2018).
- MeSH. "Expectorants". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Rami Slijmoplossende are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Rami Slijmoplossende. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
